Dr. Alexander Landfield
Board-Certified Neurologist & Medical Director
Semaglutide and Tirzepatide are both used in medical weight management, but Eastside patients should understand the difference before choosing a program. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GLP-1 and GIP pathways, which may produce stronger weight loss for some patients.
Semaglutide is often a good starting point for patients who want a proven GLP-1 option with a predictable dose-escalation path. It can reduce appetite, slow gastric emptying, and support meaningful weight loss when paired with nutrition and medical monitoring.
Tirzepatide may be considered when a patient needs a more powerful metabolic tool, has plateaued, or has goals that justify the higher medication cost. Some patients respond more strongly to Tirzepatide, but stronger does not mean better for everyone. Side effects, tolerance, budget, and medical history all matter.
The decision should be clinical, not trend-driven. A provider should review BMI, metabolic markers, medical history, medications, side-effect risk, prior attempts, and budget. Dose increases should be paced around tolerance, hydration, nutrition, and safety.
At Rani Beauty Clinic, Semaglutide and Tirzepatide options are reviewed as part of a physician-supervised plan. For Bellevue, Redmond, and other Eastside patients, the goal is not simply to start injections. The goal is a monitored plan that protects health while supporting weight loss.
Medical disclaimer: This content is educational and does not replace individualized medical advice, diagnosis, or treatment. Always consult a qualified medical professional before starting any treatment.
